News >

10-Year Trabectedin Real-World Data Demonstrate Efficacy in Sarcoma

Jason Harris
Published: Wednesday, Jul 26, 2017

Long-term follow-up showed that trabectedin (Yondelis) was associated with high rates of survival and clinical benefit rate for patients with advanced high grade soft tissue sarcomas, especially liposarcoma and leiomyosarcoma.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication